Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Detection kit for triple negative breast cancer metastasis susceptibility gene TNF-alpha mutation and detection method

A technology of triple-negative breast cancer and a detection kit, which is applied in the fields of molecular biology and genetic diagnosis, and can solve the problems of poor prognosis, high risk of triple-negative breast cancer metastasis, and no molecular biology and genetic diagnosis methods for TNBC patients , to achieve the effect of ingenious design, accurate and reliable results

Active Publication Date: 2016-03-02
SHANDONG TUMOR HOSPITAL
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although triple-negative breast cancer has a high risk of metastasis and poor prognosis, there are currently no molecular biological and genetic diagnostic methods that can assess the risk of metastasis in TNBC patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Detection kit for triple negative breast cancer metastasis susceptibility gene TNF-alpha mutation and detection method
  • Detection kit for triple negative breast cancer metastasis susceptibility gene TNF-alpha mutation and detection method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] A triple-negative breast cancer metastasis-related susceptibility gene TNF-α mutation detection kit, its components and contents are as follows: including 1.0ul of 10×PCR reaction buffer, 25mMMgCl 2 Solution 0.5ul, dNTPMixture (2.5mM) 1.0ul, TaqDNA polymerase 0.25ul (5U / ul), specific primers F and R (10uM) each 0.25ul, sterilized distilled water 6.0ul. This kit is used for one person-time detection, and the storage temperature is -20°C.

[0034] Step 1: DNA extraction from peripheral blood of patients with triple-negative breast cancer:

[0035] Genomic DNA from peripheral blood of patients was extracted using a blood genomic DNA extraction system (spin column method).

[0036] Step 2: PCR reaction, copy the target fragment:

[0037] (1) Design specific primers according to the gene sequence of the TNF-α promoter region to amplify the DNA fragment containing the rs1800629 site. The designed primer sequences are as follows:

[0038] F:5'-CCCCAAAAGAAATGGAGGCAATAGGTTTTG...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a detection kit for triple negative breast cancer metastasis susceptibility gene TNF-alpha mutation. The detection kit comprises a specific primer and a related reaction solution. Meanwhile, the invention provides a detection method of the detection kit. The detection kit is ingenious in design, simple, feasible and capable of being popularized in hospitals at different levels, helps to evaluate the tumor metastasis risk of a TNBC patient and is beneficial for early intervening and treating the patient clinically, and results are accurate and reliable.

Description

technical field [0001] The invention relates to the fields of molecular biology and gene diagnosis, and is a kit for detecting the mutation of the susceptibility gene TNF-α related to the metastasis of triple-negative breast cancer, which is predicted by detecting the 308G>A genetic variation (rs1800629) in the promoter region of the TNF-α gene Metastatic risk in triple-negative breast cancer. Background technique [0002] Triple-negative breast cancer (TNBC), as a special subtype, specifically refers to estrogen receptor (estrogen receptor, ER), progesterone receptor (progesterone receptor, PR), epidermal growth factor receptor 2 (humanepidermal growth factor receptor 2, HER2 ) are all negative breast cancers, accounting for about 15% of all breast cancers, and are more likely to occur in young women. About 1 / 3 of the patients have recurrence and metastasis within 2-3 years after surgery, and they progress rapidly until death after recurrence. Early assessment of the ri...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/68
CPCC12Q1/6886C12Q2600/112C12Q2600/118C12Q2600/156
Inventor 李慧慧孟雪宋宝翟侃常春晓刘聪徐娜商玉红
Owner SHANDONG TUMOR HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com